These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Selective serotonin reuptake inhibitors for stroke recovery: a systematic review and meta-analysis. Mead GE; Hsieh CF; Lee R; Kutlubaev M; Claxton A; Hankey GJ; Hackett M Stroke; 2013 Mar; 44(3):844-50. PubMed ID: 23362083 [No Abstract] [Full Text] [Related]
7. Early Selective Serotonin Reuptake Inhibitors for Recovery after Stroke: A Meta-Analysis and Trial Sequential Analysis. Gu SC; Wang CD J Stroke Cerebrovasc Dis; 2018 May; 27(5):1178-1189. PubMed ID: 29276014 [TBL] [Abstract][Full Text] [Related]
8. Selective serotonin reuptake inhibitors to improve outcome in acute ischemic stroke: possible mechanisms and clinical evidence. Siepmann T; Penzlin AI; Kepplinger J; Illigens BM; Weidner K; Reichmann H; Barlinn K Brain Behav; 2015 Oct; 5(10):e00373. PubMed ID: 26516608 [TBL] [Abstract][Full Text] [Related]
9. Serotonin transporter gene polymorphisms may be associated with poststroke neurological recovery after escitalopram use. Lee EJ; Oh MS; Kim JS; Chang DI; Park JH; Cha JK; Heo JH; Sohn SI; Kim DE; Kim HY; Kim J; Seo WK; Lee J; Park SW; Kim YJ; Lee BC; J Neurol Neurosurg Psychiatry; 2018 Mar; 89(3):271-276. PubMed ID: 29030421 [TBL] [Abstract][Full Text] [Related]
10. WITHDRAWN: Treatment discontinuation with selective serotonin reuptake inhibitors (SSRIs) versus tricyclic antidepressants (TCAs). Barbui C; Hotopf M; Freemantle N; Boynton J; Churchill R; Eccles MP; Geddes JR; Hardy R; Lewis G; Mason JM Cochrane Database Syst Rev; 2007 Jul; (3):CD002791. PubMed ID: 17636706 [TBL] [Abstract][Full Text] [Related]
11. Selective serotonin reuptake inhibitors, and serotonin and norepinephrine reuptake inhibitors for anxiety, obsessive-compulsive, and stress disorders: A 3-level network meta-analysis. Gosmann NP; Costa MA; Jaeger MB; Motta LS; Frozi J; Spanemberg L; Manfro GG; Cuijpers P; Pine DS; Salum GA PLoS Med; 2021 Jun; 18(6):e1003664. PubMed ID: 34111122 [TBL] [Abstract][Full Text] [Related]
12. Selective serotonin-reuptake inhibitors and recovery after stroke. Robinson RG; Adams HP Lancet Neurol; 2011 Feb; 10(2):110-1. PubMed ID: 21216671 [No Abstract] [Full Text] [Related]
13. Safety and Efficacy of SSRIs in Improving Poststroke Recovery: A Systematic Review and Meta-Analysis. Kalbouneh HM; Toubasi AA; Albustanji FH; Obaid YY; Al-Harasis LM J Am Heart Assoc; 2022 Jul; 11(13):e025868. PubMed ID: 35730636 [TBL] [Abstract][Full Text] [Related]
14. Tolerability of concomitant use of selective serotonin reuptake inhibitors or serotonin-norepinephrine reuptake inhibitors and oxymorphone extended release. Peniston JH; Hu X; Potts SL; Wieman MS; Turk DC Postgrad Med; 2012 Mar; 124(2):114-22. PubMed ID: 22437221 [TBL] [Abstract][Full Text] [Related]
15. Efficacy and tolerability of selective serotonin reuptake inhibitors on promoting motor recovery after stroke:meta-analysis of randomized controlled trials. Su D; Zhang Y; Wang A; Shao D; Xu F; Dong M; Zhao L; Hu Y; Luo H Expert Rev Neurother; 2021 Oct; 21(10):1179-1189. PubMed ID: 34538154 [TBL] [Abstract][Full Text] [Related]
16. Post-stroke depression: Mechanisms and pharmacological treatment. Villa RF; Ferrari F; Moretti A Pharmacol Ther; 2018 Apr; 184():131-144. PubMed ID: 29128343 [TBL] [Abstract][Full Text] [Related]
17. Selective serotonin reuptake inhibitors for functional independence and depression prevention in early stage of post-stroke: A meta-analysis. Zhou S; Liu S; Liu X; Zhuang W Medicine (Baltimore); 2020 Feb; 99(6):e19062. PubMed ID: 32028426 [TBL] [Abstract][Full Text] [Related]
18. Pharmacogenetics of selective serotonin reuptake inhibitors in pediatric depression and anxiety. Kronenberg S; Frisch A; Rotberg B; Carmel M; Apter A; Weizman A Pharmacogenomics; 2008 Nov; 9(11):1725-36. PubMed ID: 19018726 [TBL] [Abstract][Full Text] [Related]
19. Selective serotonin reuptake inhibitors versus tricyclic and heterocyclic antidepressants: comparison of drug adherence. Barbui C; Hotopf M; Freemantle N; Boynton J; Churchill R; Eccles MP; Geddes JR; Hardy R; Lewis G; Mason JM Cochrane Database Syst Rev; 2000; (4):CD002791. PubMed ID: 11034764 [TBL] [Abstract][Full Text] [Related]
20. Comparison of agomelatine and selective serotonin reuptake inhibitors/serotonin-norepinephrine reuptake inhibitors in major depressive disorder: A meta-analysis of head-to-head randomized clinical trials. Huang KL; Lu WC; Wang YY; Hu GC; Lu CH; Lee WY; Hsu CC Aust N Z J Psychiatry; 2014 Jul; 48(7):663-71. PubMed ID: 24604920 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]